febuxostat and Necrosis
febuxostat has been researched along with Necrosis in 3 studies
Research
Studies (3)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors
Authors | Studies |
---|---|
Chiba, K; Iino, T; Kataoka, T; Odake, K; Sudo, A; Tsujii, M | 1 |
Kataoka, H; Rock, KL; Yang, K | 1 |
Chen, A; Li, Y; Song, X; Wang, S; Wang, X; Yang, P; Zhao, C | 1 |
Other Studies
3 other study(ies) available for febuxostat and Necrosis
Article | Year |
---|---|
Febuxostat treatment attenuates oxidative stress and inflammation due to ischemia-reperfusion injury through the necrotic pathway in skin flap of animal model.
Topics: Animals; Disease Models, Animal; Febuxostat; Inflammation; Necrosis; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2021 |
The xanthine oxidase inhibitor Febuxostat reduces tissue uric acid content and inhibits injury-induced inflammation in the liver and lung.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Death; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Enzyme Inhibitors; Febuxostat; Gastroesophageal Reflux; Gout Suppressants; Liver; Lung; Lung Injury; Male; Mice, Inbred C57BL; Necrosis; Neutrophil Infiltration; Peritoneum; Peritonitis; Thiazoles; Uric Acid; Xanthine Oxidase | 2015 |
Febuxostat pretreatment attenuates myocardial ischemia/reperfusion injury via mitochondrial apoptosis.
Topics: Animals; Animals, Newborn; Apoptosis; Caspase 3; Caspase 9; Cytochromes c; Febuxostat; Heart Function Tests; Heart Ventricles; Hypoxia; Male; Membrane Potential, Mitochondrial; Mice, Inbred C57BL; Mitochondria; Models, Biological; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Necrosis; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction | 2015 |